Article

Implementing MACRA

Physicians should understand the key features of MACRA and changes that lie ahead, say Duke University healthcare policy experts writing in JAMA.

The Centers for Medicare & Medicaid Services (CMS) has released guidelines for implementing the Medicare Access and CHIP Reauthorization Act (MACRA) which will place most physicians in the pay-for-performance Merit-Based Incentive Payment System (MIPS) beginning in 2019.

MIPS will adjust payments based on measures derived from prior care. Physicians can be exempt from MIPS and receive bonus payments by demonstrating sufficient participation in advanced alternative payment models (APMs).

Writing in the June 14 issue of JAMA, Jeffrey D. Clough, M.D., and Mark McClellan, M.D., Ph.D., both of Duke University, say that physicians should understand the key features of the law and changes that lie ahead.

“Despite its size and scope, the rule leaves many questions unsettled, including certainty about the best pathways forward for many types of physicians, and how much influence the reforms will have on quality of care and spending for Medicare beneficiaries. Physicians now have a critical opportunity to improve the proposal and develop and implement reforms to maximize its effectiveness,” they wrote.

For more information:

-  American College of Rheumatology

-  Coalition of State Rheumatology Organizations

-  Rheumatology Practice Management

Please click on the following image to view a summary of the MIPS composite performance score.

[[{"type":"media","view_mode":"media_crop","fid":"49533","attributes":{"alt":"","class":"media-image","id":"media_crop_2044505822111","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5999","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]

 

References:

Jeffrey D. Clough, MD, MBA; Mark McClellan, MD, PhD.

"Implementing MACRA:  Implications for Physicians and for Physician Leadership."

 JAMA. 2016;315(22):2397-2398. doi:10.1001/jama.2016.7041. 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.